Singapore Company Reports Stem Cell Progress

Source: E-Commerce Times
Posted: July 28, 2006 5:27 PM PT

Summary:

ES Cell International (ESI), a Singapore biotech company, announced that it has produced and stored four new clinically compliant human embryonic stem cell (hESC) lines, and that another four lines should be stored within the next four to five weeks. The development is expected to facilitate laboratory research while allowing researchers the option of later securing clinically compliant versions of exactly the same cell lines they are using for research.

Commentary: Hopefully this advancement will accelerate the pace of research and rate of discovery in the field of stem cell research and hasten the development of new treatments for diseases, injuries and medical conditions.